GlassScriptPhysician profile
Clifton Peay
NPI 1821154089
$2,946.22
in general payments reported to CMS, 2019-2025
18 companies · $756 in 2025
The $756 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $51.32 · 2021: $167 · 2022: $480 · 2023: $275 · 2024: $760 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,790.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $1,170.14 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $329.70 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Alcon Vision LLC | $325.46 | 2019-2025 | Simbrinza, Rhopressa, Rocklatan |
| Allergan, INC. | $225.50 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $186.05 | 2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $136.27 | 2024 | Acthar |
| Aerie Pharmaceuticals, INC. | $128.32 | 2019-2021 | |
| Shire North American Group INC | $118.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $108.82 | 2019-2023 | |
| Thea Pharma INC. | $44.37 | 2022 | |
| Biotissue Holdings INC. | $36.17 | 2019-2023 | |
| Abbvie INC. | $24.90 | 2024 | |
| Rxsight INC | $24.07 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Oyster Point Pharma, INC. | $23.93 | 2023 | Tyrvaya |
| Harrow Eye, LLC | $18.95 | 2024 | Vevye |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $16.08 | 2022 | |
| Eyevance Pharmaceuticals LLC | $15.78 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clifton Peay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.